etravirine

FDA Drug Profile — etravirine, Intelence, Etravirine

etravirine is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including etravirine, Intelence, Etravirine. Available dosage form: tablet.

Drug details

Generic Name
etravirine
Brand Names
etravirine, Intelence, Etravirine
Application Number
ANDA214196
Sponsor
Amneal Pharmaceuticals NY LLC
NDC Codes
12
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
ETRAVIRINE

Indications and Usage

1 INDICATIONS AND USAGE Etravirine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-experienced adult patients and pediatric patients 2 years of age and older [see Microbiology (12.4) and Clinical Studies (14)] . Etravirine is a human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for treatment of HIV-1 infection in treatment-experienced patients 2 years of age and older. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.